Cover image not available

Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive : Understanding NICE guidance : Informati

National Institute for Health and Clinical Excellence

Publication Data

Title Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive : Understanding NICE guidance : Informati
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2012
Publication location London
Language English

Descriptive Notes

Issue date: June 2012.

Topics

Breast :: Cancer :: Chemotherapy :: England
Breast :: Cancer :: Chemotherapy :: Wales
Lapatinib
Trastuzumab
Enzyme inhibitors

Catalogue Data

OBNB ID GBB586376
ISBN 10 1849368740
ISBN 13 9781849368742
Type BibliographicResource, Book
Dewey Classification 616.99449061

ISBD

P1053 1 online resource (6 pages).

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive : Understanding NICE guidance : Informati by National Institute for Health and Clinical Excellence. ISBN 9781849368742. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.